Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., July 20, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
LONDON and RALEIGH, N.C., July 20, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development…
Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than…
July 20, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
SINGAPORE, July 20, 2023 – (ACN Newswire) – The Asia Travel Technology Industry Association (ATTIA)…
SHANGHAI, China, July 19, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,”…
Vancouver, British Columbia–(Newsfile Corp. – July 19, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
HONG KONG, Jul 20, 2023 – (ACN Newswire) – This week sees the announcement that…
HO CHI MINH CITY, VIETNAM, Jul 20, 2023 – (ACN Newswire) – Global renewable energy…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 (GLOBE NEWSWIRE) —…
Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
CHANDLER, Ariz.–(BUSINESS WIRE)–Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, will release its…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
HOUSTON, July 19, 2023 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or…
HONG KONG, Jul 20, 2023 – (ACN Newswire) – The 33rd HKTDC Hong Kong Book…
Firm’s partner presents on the power of artificial intelligence to aid people with disabilities and…
Second Quarter 2023 Summary Results Total revenues of $207.4 million, down 12.6% YoY Operating income…
Seven impressive fintechs set to showcase their innovations in front of the largest independent gathering…
European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva…